Call +44 (0)20 7496 3000
Email enquiries@singercm.com
SIREX (Log in)
Get In Touch
Home Markets Equity Research

Equity Research

A highly reputable team who selectively cover UK corporate and non-corporate stocks ranging from microcap up to the FTSE 250.

5,500
Professional investors receive our research
120 +
Stocks under formal research coverage
13
Core sectors covered including a specialist macro sector, 'Macro Edge'

Our output spans from comprehensive company and thematic analysis to innovative quant, strategy and cross-sector reports.

Our Products

Daily Research & Thematic Notes

Providing our clients with high-quality financial analysis and thought-provoking insights both in written form and through audio and video media.

'Macro Edge' - Macro Economics

Specialist economic analysis ranging from daily reactive market updates, weekly bulletin notes and global macro markets reports.

‘SIREX’ Digital Platform

An evolutionary platform which provides investors with a more advanced way of engaging with our research, moving away from traditional ‘static’ research to a dynamic display of information and content; a key USP to our research product.

Events & Conferences

Bringing pivotal topics and key analysis to life in the form of webinars, conferences, lunch & evening events and panel discussions. To hear about our upcoming events please email events@singercm.com.

Introducing SIREX – A new, dynamic way to engage with research

SIREX is an evolutionary digital platform which was launched in January 2024. The platform provides our clients with a more advanced way of engaging with Singer Capital Markets’ research, as well as providing enhanced levels of information and content on research companies under our coverage. Unlike other platforms already available in the market, SIREX is far more than just a traditional library of research, providing unique functionality and tools such as individual company pages which contain live data analysis, forecasts and views, as well as interactive charts and media.
Video Cover

Our Latest Reports

July 2025
Read
Half Year Macro & Equity Market Report 2025 - Searching for the 4th "C" - In the Foothills of the UK Market Recovery
Jamie Constable, Markets Strategist at Singer Capital Markets, reviews H1 of 2025 and looks at how it has turned out as compared to our previous 2025 Outlook Report We thought Trump 2.0 could bring increased volatility in financial markets and we haven’t been disappointed so far in 2025! From tariffs to Liberation Day and “bombs as the new diplomacy” financial markets have had a lot to deal with. We search for the “4th C,” Confidence and see UK markets as in the foothills of their recovery.
Read Post

Interested in receiving insights on our latest research coverage and more? Sign up to our mailing list:

    Dr. Karl Keegan

    Head of Research
    Call +44 (0)20 7496 3187 Email karl.keegan@singercm.com
    Testimonials

    Don’t just take our word for it

    Nik Philpot
    Chief Executive Officer, Eckoh
    We have had a successful relationship with SCM that has lasted more than a decade. They have backed us and believed in the business from the outset, and this has undoubtedly played a significant role in our ongoing success
    Finance Director
    Liontrust Asset Management
    The team have demonstrated an exceptionally proactive approach to promoting our company and have led the way in broadening our shareholder base, trading our shares and improving liquidity. They are a stand-out firm.
    Fund Manager
    Lombard Odier Asset Management
    We highly value Singer Capital Markets' strong expertise in the small and mid cap market and its deep access to innovative and fast-growing companies.
    Fund Manager
    Canaccord Genuity Wealth Management
    The Singer Capital Markets franchise is within the top echelons of UK advisory and broking houses.
    Christopher Walters
    Chief Executive Officer, Pressure Technologies
    Chemistry and a genuine interest in our business were major factors in the choice of Singer. From the outset, it was clear that they take a partnership approach to engaging with management teams. From corporate advisory through to sales and research, the whole team took time to properly understand the business, the vision, our strategic priorities and value creation plan.